dermatology lesions

Tools and Technologies for More Objective Dermatology Clinical Trials

From the reliance on visual assessments to the lack of a consensus on instruments for assessment and monitoring, there are many causes for this subjectivity concern. However, there are a variety of tools and technologies available that can help make this process more objective.

FDA IND Submissions, Novella Clinical

What You Need to Know About Submitting an IND to the FDA

As the nation’s principal authority overseeing the safety of food, drugs and cosmetics, the US Food and Drug Administration (FDA) requires manufacturers to provide proof of the safety and efficacy of their drugs before bringing them to market. This has … Read More

Seamless single arm clinical trials, a faster route to FDA approvals, man walking across a divide, bridged by yellow dashed line

Paving the Way for More Seamless Oncology Trials

The US Food and Drug Administration (FDA) is highlighting efforts to promote innovative trial design that will accelerate the typically time-consuming and expensive process of developing and testing drugs for cancer patients. New trial designs, often referred to as seamless … Read More

immuno-oncology trials, standing out among the crowd, yellow umbrella among white umbrellas

A Silver Lining to the Immuno-Oncology “Gold Rush”

With the recent clinical success of cancer immunotherapeutics, such as checkpoint inhibitors, there has been a dramatic influx of public, academic, and industrial interest in the immuno-oncology (IO) field. Many pharmaceutical companies are looking for the next breakthrough drug and … Read More

Physician Spotlight

Dr. Michael Armstrong: Academic Excellence in Oncology

Michael Armstrong, MD, PhD, has deep experience as both a bench and clinical researcher. His career combines his passion for research and his interest in pediatrics, especially rare hematologic and oncological diseases. His career represents a true intersection of formative … Read More

Physician Spotlight, grey color button

Dr. Valery Chatikhine: Seasoned Oncology Expertise

Valery Chatikhine, MD, PhD brings to Novella Clinical nearly 30 years of experience spanning two continents and nearly every facet of oncology-hematology R&D. With both his parents being physicians, Dr. Chatikhine was perhaps destined to have a career in medicine. … Read More